Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2015

Pharmaceutical Microbiology

21 Jan 2015 - 22 Jan 2015 - London, UK

Bookmark and Share

Excellence in the Prevention, Detection and Management of Microorganisms

Set to take place on 21st and 22nd January 2015, the 4th annual event in the sell-out Pharmaceutical Microbiology series will bring together all levels of industry professionals, providing essential insights into the latest advancements in practice and technology, developments in regulation and the global harmonisation of evolving microbiology methods.

Join us as we ask questions such as: What are the best approaches in contamination control? Where does microbiological risk assessment interact with HACCP? How do we develop and manage the sterilisation and validation process? When can we use a scoring system to avoid unnecessary microbiological testing? What are the latest approaches to preventing biofilms? 

Hear presentations from an array of market leaders such as GSK, Genzyme, Abbott, MedImmune and AstraZeneca, address real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. 


  • Olivier Chancel, Sterility and Aseptic Process Assurance Expert, Merial Sas – CONFERENCE CHAIRMAN
  • Ruth Daniels, Head of MSAT, Microbiology, Genzyme
  • Sara Gamberini, Molecular Biology Scientist, Merck Serono
  • Hans Noordergraaf, Microbiologist, Abbott Biologicals
  • Thomas Schwartz, Microbiology & Molecular Biology Group Leader, Forschungszentrum Karlsrube Gmbh
  • Tim Eaton, Sterile Manufacturing, Specialist, AstraZeneca
  • Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline
  • Phil Duncanson, Director of QC, MedImmune


  • Discover the latest in the development and management of sterilisation and validation processes
  • Understand data review and analysis for pharmaceutical microbiology
  • Benefit from listening to developments in bioburden and biofilm control strategies
  • Look in depth at issues of objectionable organism management
  • Hear specialist advice on contamination control and risk assessment to minimise costs and maximise efficiency
  • Share the wisdom of respected consultants and get a regulatory perspective on recent changes and issues under review.

“I have attended the last 2 Microbiology conference and have appreciated that outstanding experts from the pharmaceutical industry, and international academia presented various microbiological aspects with a series of case studies to focus on the practical knowledge, the “know how” which can be directly applied on daily business.  I look forward to attend this new conference in London as it is likely to provide an incredible forum for open discussions with speakers and attendants. - Oliver Chancel, Merial Sas

To download a brochure or to book a place visit:

Alternatively contact the team on Tel +44 (0) 870 9090 711 or email 

Further information
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos